Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

113.08
Delayed Data
As of Oct 20
 +1.05 / +0.94%
Today’s Change
81.12
Today|||52-Week Range
121.45
+20.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line141.4M158.5M230.2M186.1M
 
 
 
 
 
Depreciation18.2M19.1M21.1M18.9M
 
 
 
 
 
Total Other Cash Flow-2.9M10.2M21.3M49.1M
 
 
 
 
 
Funds From Operations153.9M153.0M309.2M261.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-52.0M-48.1M180.9M63.5M
 
 
 
 
 
Net Cash Flow - Operating Activities205.9M201.1M128.3M197.7M
 
 
 
 
 
 
InvestingIncrease In Investments-291.7M-154.3M-171.8M-671.9M
 
 
 
 
 
Decrease In Investments347.7M297.2M423.0M98.7M
 
 
 
 
 
Capital Expenditures-48.1M-63.2M-15.9M-58.0M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-82.0M-2.8M
 
 
 
Other Investing - Uses0.00-1.2M----
 
 
Other Investing - Sources-3.8M1.7M600.0K-500.0K
 
 
 
 
 
Net Cash Flow Investing3.9M80.2M151.2M-638.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings8.7M228.9M377.4M608.0M
 
 
 
 
 
Long Term Debt Reduction-6.4M-5.7M-353.4M-454.8M
 
 
 
 
 
Net Proceeds Stock Sale38.1M20.6M23.1M45.6M
 
 
 
 
 
Common Preferred Redeemed-200.0K-281.4M-437.4M-73.8M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing19.4M11.8M0.00800.0K
 
 
 
 
Other Uses - Financing-4.2M--1.0M--
 
 
 
Net Cash Flow - Financing63.8M5.1M-391.3M126.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.5M-1.3M1.0M2.6M
 
 
 
 
 
 
Net Change In Cash273.6M286.4M-111.8M-313.7M